← Leaderboards
Amir Seyedmousavi
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Immunocompromised Host”
- David D. McManus · Univ Of Massachusetts Med Sch Worcester$40,621,016
- Bryan O Buchholz · University Of Massachusetts Lowell$40,621,016
- L David Sibley · Washington University$35,604,385
- Joseph Heitman · Duke University$17,351,155
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,660,001
- Ekaterina Heldwein · Children'S Hospital Boston$15,448,805
Research focus
Immunocompromised HostPathogenic FungusTraumaFungusInterestMolecularLifeUnited States National Institutes Of HealthMycosesAnimalsFungal Drug ResistanceHospitalizationAntifungal TherapyLaboratoriesIn VivoMortalityGeneticDiagnosticInfectionComplexAlgorithmsDiagnostic ProcedureBiologyAffect
Grant awards (8)
Comparative Genomics and Pathogenicity of Agents of Human and Animal Fungal Infections$0
ZIA · FY2025 · CL · contact PI
Antifungal Resistance and Novel Mycology Diagnostics$0
ZIA · FY2025 · CL · contact PI
Comparative Genomics and Pathogenicity of Agents of Human and Animal Fungal Infections$0
ZIA · FY2024 · CL · contact PI
Antifungal Resistance and Novel Mycology Diagnostics$0
ZIA · FY2024 · CL · contact PI
Comparative Genomics and Pathogenicity of Agents of Human and Animal Fungal Infections$0
ZIA · FY2023 · CL · contact PI
Antifungal Resistance and Novel Mycology Diagnostics$0
ZIA · FY2023 · CL · contact PI
Molecular Epidemiology of Clinically Important Fungi and Pathobiology of Fungal Infections$0
ZIA · FY2022 · CL · contact PI
Antifungal Resistance and Novel Mycology Diagnostics$0
ZIA · FY2022 · CL · contact PI